Cycle Pharmaceuticals
Damien Sango is Cycle’s Manager of U.S. Market Access and Distribution. Damien oversees the development and implementation of Cycle’s U.S. Market Access and Distribution strategy for existing and new products, as well as Cycle’s relationships with the relevant industry partners.
Damien joined Cycle in 2019 as a member of the Regulatory Affairs team, supporting the global rollout and launch of Nityr in Rest of World markets before moving into business focused roles in 2020, supporting the asset evaluation of Cycle’s Branded Generic portfolio.
Prior to joining Cycle, Damien worked in Regulatory Affairs and R&D Manufacturing for CSL Behring.
Damien received his MBA from Melbourne Business School at the University of Melbourne in Australia.
This person is not in any offices
Cycle Pharmaceuticals
1 followers
Cycle Pharmaceuticals was founded in 2012 with the sole aim of delivering best-in-class drug treatments and services to the under-served rare disease patient community.